The Investor Relations website contains information about Surmodics, Inc ... Stock Quote (SRDX). $26.51. Price. +0.09. Change. 12,995. Volume. $39.41. Yr High.
Surmodics to Participate in Upcoming Investor Conferences in March and April. February 1, 2024. Surmodics Reports First Quarter of Fiscal Year 2024 Financial ...
Surmodics, Inc. is a leading provider of surface modification, drug delivery, and in vitro diagnostic technologies to the healthcare industry.
People also ask
What are the results of Surmodics?
What do Surmodics do?
How many employees does Surmodics have?
(Nasdaq: SRDX), a leading provider of medical ... Annual Report on Form 10-K for ... Surmodics Investor Inquiries. Jack Powell, Investor Relations. ir@surmodics.
Jan 16, 2024 · (Nasdaq: SRDX), a leading provider of ... Jack Powell, Investor Relations ir@surmodics ... Jack Powell, Investor Relations ir@surmodics.com ...
Get the latest insights on Surmodics, Inc. Common Stock (SRDX) with press releases and corporate news to help you in your trading and investing decisions.
4 days ago · Investors in Surmodics (NASDAQ:SRDX) have unfortunately lost 54% over the last three years.
10 hours ago · Will SurModics (SRDX) Report Negative Q2 Earnings? What You Should ... Investor Relations · Contact · Careers · Advertise · Mobile Apps · Nasdaq ...
SRDX / Surmodics, Inc. - SEC Filings, Annual Report, Proxy Statement · Overview · Chart · Owners. Institutional Owners Retail Ownership Net Long/ ...
Jan 16, 2024 · (Nasdaq: SRDX), a leading provider of medical device and in vitro ... Contacts. Surmodics Investor Inquiries: Jack Powell, Investor Relations